BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15077196)

  • 21. A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.
    Emiliusen L; Gough M; Bateman A; Ahmed A; Voellmy R; Chester J; Diaz RM; Harrington K; Vile R
    Gene Ther; 2001 Jul; 8(13):987-98. PubMed ID: 11438833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia.
    Licht JD; Shaknovich R; English MA; Melnick A; Li JY; Reddy JC; Dong S; Chen SJ; Zelent A; Waxman S
    Oncogene; 1996 Jan; 12(2):323-36. PubMed ID: 8570209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
    Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1.
    Fang D; Setaluri V
    Biochem Biophys Res Commun; 1999 Mar; 256(3):657-63. PubMed ID: 10080955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic HoxB7 requires TALE cofactors and is inactivated by a dominant-negative Pbx1 mutant in a cell-specific manner.
    Fernandez LC; Errico MC; Bottero L; Penkov D; Resnati M; Blasi F; Caré A
    Cancer Lett; 2008 Aug; 266(2):144-55. PubMed ID: 18378073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein.
    Schefe JH; Menk M; Reinemund J; Effertz K; Hobbs RM; Pandolfi PP; Ruiz P; Unger T; Funke-Kaiser H
    Circ Res; 2006 Dec; 99(12):1355-66. PubMed ID: 17082479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of melanoma metastasis.
    Bar-Eli M
    J Cell Physiol; 1997 Nov; 173(2):275-8. PubMed ID: 9365536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
    Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
    Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A.
    Yeyati PL; Shaknovich R; Boterashvili S; Li J; Ball HJ; Waxman S; Nason-Burchenal K; Dmitrovsky E; Zelent A; Licht JD
    Oncogene; 1999 Jan; 18(4):925-34. PubMed ID: 10023668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
    Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
    J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of integrin alpha5beta1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma.
    Béliveau A; Bérubé M; Rousseau A; Pelletier G; Guérin SL
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2363-72. PubMed ID: 10892885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
    Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
    Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
    Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H
    Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of promyelocytic leukemia zinc finger protein on the proliferation of cultured human corneal endothelial cells.
    Joko T; Nanba D; Shiba F; Miyata K; Shiraishi A; Ohashi Y; Higashiyama S
    Mol Vis; 2007 Apr; 13():649-58. PubMed ID: 17515885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional repression of the microphthalmia gene in melanoma cells correlates with the unresponsiveness of target genes to ectopic microphthalmia-associated transcription factor.
    Vachtenheim J; Novotna H; Ghanem G
    J Invest Dermatol; 2001 Dec; 117(6):1505-11. PubMed ID: 11886515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of α5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines.
    Landreville S; Vigneault F; Bergeron MA; Leclerc S; Gaudreault M; Morcos M; Mouriaux F; Salesse C; Guérin SL
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):643-55. PubMed ID: 21592318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Hoxb2 by APL-associated PLZF protein.
    Ivins S; Pemberton K; Guidez F; Howell L; Krumlauf R; Zelent A
    Oncogene; 2003 Jun; 22(24):3685-97. PubMed ID: 12802276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients.
    Brunner G; Reitz M; Schwipper V; Tilkorn H; Lippold A; Biess B; Suter L; Atzpodien J
    Cancer Biother Radiopharm; 2008 Aug; 23(4):451-9. PubMed ID: 18771349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.